{"disease":{"id":"maximum-tolerated-dose","name":"maximum tolerated dose"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07017114","title":"Pentoxifylline PKB171 Gel in Healthy Females Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Prokrea BCN, S.L.","has_results":false},{"nct_id":"NCT04138381","title":"Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Grupo Espanol de Investigacion en Sarcomas","has_results":false},{"nct_id":"NCT03082846","title":"Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Xue Xiaoying","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}